Fralick M - Search Results

1

Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study.

Fralick M, Chen SK, Patorno E, Kim SC. Fralick M, et al. Ann Intern Med. 2020 Feb 4;172(3):186-194. doi: 10.7326/M19-2610. Epub 2020 Jan 14. Ann Intern Med. 2020. PMID: 31931526 Free PMC article.

2

Sodium-glucose cotransporter 2 inhibitors for treating diabetes mellitus.

Goldberg N, Fralick M. Goldberg N, et al. Among authors: fralick m. CMAJ. 2017 May 23;189(20):E724. doi: 10.1503/cmaj.161455. CMAJ. 2017. PMID: 28536128 Free PMC article. No abstract available.

3

Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.

Fralick M, Schneeweiss S, Patorno E. Fralick M, et al. N Engl J Med. 2017 Jun 8;376(23):2300-2302. doi: 10.1056/NEJMc1701990. N Engl J Med. 2017. PMID: 28591538 No abstract available.

4

Use of Health Care Databases to Support Supplemental Indications of Approved Medications.

Fralick M, Kesselheim AS, Avorn J, Schneeweiss S. Fralick M, et al. JAMA Intern Med. 2018 Jan 1;178(1):55-63. doi: 10.1001/jamainternmed.2017.3919. JAMA Intern Med. 2018. PMID: 29159410 Free PMC article.

5

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Amputation: Results and Challenges From the Real World.

Fralick M, Patorno E, Fischer MA. Fralick M, et al. JAMA Intern Med. 2018 Sep 1;178(9):1199-1200. doi: 10.1001/jamainternmed.2018.3025. JAMA Intern Med. 2018. PMID: 30105365 No abstract available.

6

Fracture Risk After Initiation of Use of Canagliflozin: A Cohort Study.

Fralick M, Kim SC, Schneeweiss S, Kim D, Redelmeier DA, Patorno E. Fralick M, et al. Ann Intern Med. 2019 Feb 5;170(3):155-163. doi: 10.7326/M18-0567. Epub 2019 Jan 1. Ann Intern Med. 2019. PMID: 30597484 Free PMC article.

7

Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect.

Fralick M, Sacks CA, Kesselheim AS. Fralick M, et al. JAMA Intern Med. 2019 Feb 1;179(2):224-230. doi: 10.1001/jamainternmed.2018.6112. JAMA Intern Med. 2019. PMID: 30615021 Free PMC article.

8

Fracture Risk After Initiation of Use of Canagliflozin.

Fralick M, Kim SC, Schneeweiss S, Kim D, Redelmeier DA, Patorno E. Fralick M, et al. Ann Intern Med. 2019 Jul 2;171(1):80. doi: 10.7326/L19-0320. Ann Intern Med. 2019. PMID: 31261403 No abstract available.

9

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.

Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Dave CV, et al. Among authors: fralick m. Ann Intern Med. 2019 Aug 20;171(4):248-256. doi: 10.7326/M18-3136. Epub 2019 Jul 30. Ann Intern Med. 2019. PMID: 31357213 Free PMC article.

10

Desmopressin and the risk of hyponatremia: A population-based cohort study.

Fralick M, Schneeweiss S, Wallis CJD, Jung EH, Kesselheim AS. Fralick M, et al. PLoS Med. 2019 Oct 21;16(10):e1002930. doi: 10.1371/journal.pmed.1002930. eCollection 2019 Oct. PLoS Med. 2019. PMID: 31634354 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

176 results

Search Page